Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared on LinkedIn:
“Recognition for a Urologist Who Believes in Interventional Radiotherapy (Brachytherapy) for Prostate Cancer!
Highlights from Day 1 at the GEC-ESTRO Annual Workshop 2026 in Seville, Spain. GEC-ESTRO Recognition Award.
Congratulations to Prof. Stefan Machtens, a dedicated urologist and strong advocate for interventional radiotherapy (brachytherapy) in the management of prostate cancer!
Keynote Lecture:
‘Incidence and Management of Side Effects of Prostate Brachytherapy’
Speaker: Prof. Stefan Machtens

An important lecture addressing one of the essential aspects of prostate cancer treatment: balancing excellent oncological outcomes with treatment-related toxicity and quality of life.
Key Clinical Considerations:
- Patient Selection – Identifying suitable candidates for prostate interventional radiotherapy (brachytherapy).
- Toxicity Management – Recognizing, preventing, and managing treatment-related urinary, gastrointestinal, and sexual side effects.
- Quality of Life – Maintaining functional outcomes alongside effective cancer control.
- Multidisciplinary Collaboration – Strengthening cooperation between urologists, radiation oncologists, and medical physicists.
My Personal Takeaway: The future of prostate cancer treatment depends on collaboration, not competition, between specialties.
Recognizing a urologist who supports interventional radiotherapy (brachytherapy) sends an important message:
The best treatment decisions are made when different specialties work together, placing the patient at the center of every decision.
Congratulations once again to Prof. Stefan Machtens on this well-deserved recognition!
One Patient. One Multidisciplinary Team. One Shared Goal: Better Cancer Care.”
You may also be interested in:
Adam Weiner: ACS Makes Major Shift Toward Routine PSA-Based Prostate Cancer Screening
New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing
